abnormal osteoid morphology_Tg(APOE-FGF23*R176Q)#Ack/0

http://metadb.riken.jp/0010924IC57BL6JCBATgAPOEFGF23R176QAck0TgAPOEFGF23R176QAck

abnormal osteoid morphology_Tg(APOE-FGF23*R176Q)#Ack/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Andrew C Karaplis
  http://metadb.riken.jp/db/mgi_rdf/MGI:5465568

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(APOE-FGF23*R176Q)#Ack/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(APOE-FGF23*R176Q)#Ack

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * CBA

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal osteoid morphology
  http://purl.obolibrary.org/obo/MP_0010924

文献

http://purl.org/net/cito/citesAsAuthority

• Andrew C. Karaplis, et.al., Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice., Endocrinology, 2012, 153
  http://rdf.ncbi.nlm.nih.gov/pubmed/23038738